Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy

Purpose. The recurrence of CBD stone is still observed in a considerable number of patients. The study was to evaluate the risk factors for recurrence of symptomatic CBD stone in patients who underwent cholecystectomy after the removal of CBD stone. Methods. The medical records of patients who under...

Full description

Saved in:
Bibliographic Details
Main Authors: Ju Hyun Oak, Chang Nyol Paik, Woo Chul Chung, Kang-Moon Lee, Jin Mo Yang
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/417821
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850232334410842112
author Ju Hyun Oak
Chang Nyol Paik
Woo Chul Chung
Kang-Moon Lee
Jin Mo Yang
author_facet Ju Hyun Oak
Chang Nyol Paik
Woo Chul Chung
Kang-Moon Lee
Jin Mo Yang
author_sort Ju Hyun Oak
collection DOAJ
description Purpose. The recurrence of CBD stone is still observed in a considerable number of patients. The study was to evaluate the risk factors for recurrence of symptomatic CBD stone in patients who underwent cholecystectomy after the removal of CBD stone. Methods. The medical records of patients who underwent removal of CBD stone with subsequent cholecystectomy were reviewed. The risk factors for the recurrence of symptomatic CBD stone were compared between the recurrence and the nonrecurrence group. Results. The mean follow-up period was 40.6 months. The recurrence of symptomatic CBD stones was defined as the detection of bile duct stones no sooner than 6 months after complete clearance of CBD stones, based on symptoms or signs of biliary complication. 144 patients (68 males, 47.2%) were finally enrolled and their mean age was 59.8 (range: 26~86) years. The recurrence of CBD stone occurred in 15 patients (10.4%). The mean period until first recurrence was 25.9 months. The presence of type 1 or 2 periampullary diverticulum and multiple CBD stones were the independent risk factors. Conclusion. For the patients with type 1 or 2 periampullary diverticulum or multiple CBD stones, careful followup is needed for the risk in recurrence of symptomatic CBD stone.
format Article
id doaj-art-00a4519ffbb849e982abf4a9cdde9e25
institution OA Journals
issn 1687-6121
1687-630X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-00a4519ffbb849e982abf4a9cdde9e252025-08-20T02:03:14ZengWileyGastroenterology Research and Practice1687-61211687-630X2012-01-01201210.1155/2012/417821417821Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after CholecystectomyJu Hyun Oak0Chang Nyol Paik1Woo Chul Chung2Kang-Moon Lee3Jin Mo Yang4Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Ji-dong, Paldal-gu, Gyeonggi-do, Suwon 442-723, Republic of KoreaDepartment of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Ji-dong, Paldal-gu, Gyeonggi-do, Suwon 442-723, Republic of KoreaDepartment of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Ji-dong, Paldal-gu, Gyeonggi-do, Suwon 442-723, Republic of KoreaDepartment of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Ji-dong, Paldal-gu, Gyeonggi-do, Suwon 442-723, Republic of KoreaDepartment of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Ji-dong, Paldal-gu, Gyeonggi-do, Suwon 442-723, Republic of KoreaPurpose. The recurrence of CBD stone is still observed in a considerable number of patients. The study was to evaluate the risk factors for recurrence of symptomatic CBD stone in patients who underwent cholecystectomy after the removal of CBD stone. Methods. The medical records of patients who underwent removal of CBD stone with subsequent cholecystectomy were reviewed. The risk factors for the recurrence of symptomatic CBD stone were compared between the recurrence and the nonrecurrence group. Results. The mean follow-up period was 40.6 months. The recurrence of symptomatic CBD stones was defined as the detection of bile duct stones no sooner than 6 months after complete clearance of CBD stones, based on symptoms or signs of biliary complication. 144 patients (68 males, 47.2%) were finally enrolled and their mean age was 59.8 (range: 26~86) years. The recurrence of CBD stone occurred in 15 patients (10.4%). The mean period until first recurrence was 25.9 months. The presence of type 1 or 2 periampullary diverticulum and multiple CBD stones were the independent risk factors. Conclusion. For the patients with type 1 or 2 periampullary diverticulum or multiple CBD stones, careful followup is needed for the risk in recurrence of symptomatic CBD stone.http://dx.doi.org/10.1155/2012/417821
spellingShingle Ju Hyun Oak
Chang Nyol Paik
Woo Chul Chung
Kang-Moon Lee
Jin Mo Yang
Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy
Gastroenterology Research and Practice
title Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy
title_full Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy
title_fullStr Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy
title_full_unstemmed Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy
title_short Risk Factors for Recurrence of Symptomatic Common Bile Duct Stones after Cholecystectomy
title_sort risk factors for recurrence of symptomatic common bile duct stones after cholecystectomy
url http://dx.doi.org/10.1155/2012/417821
work_keys_str_mv AT juhyunoak riskfactorsforrecurrenceofsymptomaticcommonbileductstonesaftercholecystectomy
AT changnyolpaik riskfactorsforrecurrenceofsymptomaticcommonbileductstonesaftercholecystectomy
AT woochulchung riskfactorsforrecurrenceofsymptomaticcommonbileductstonesaftercholecystectomy
AT kangmoonlee riskfactorsforrecurrenceofsymptomaticcommonbileductstonesaftercholecystectomy
AT jinmoyang riskfactorsforrecurrenceofsymptomaticcommonbileductstonesaftercholecystectomy